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Aim: To identify and understand the main unmet needs of individuals with Type 2 diabetes (T2D). Mate-
rials & methods: An online survey was conducted in Brazil, China and Russia of individuals with recently
diagnosed T2D. Results: The survey, involving 300 individuals with T2D, identified a need for more in-
formation regarding food/diet and for increased awareness of T2D symptoms. While most participants
(94%) had experienced symptoms prior to their diagnosis, only 55% of symptomatic individuals sought
medical attention. Conclusion: Novel strategies to increase awareness of diabetes should be developed
and tested, and may enable earlier diagnosis and improve patients’ quality of life.
Lay abstract: Type 2 diabetes (T2D) negatively impacts an individual’s health-related quality of life and
represents a significant burden of disease worldwide. Although previous studies have examined the unmet
needs of patients with diabetes, no recent studies have evaluated the needs of individuals with T2D in
Brazil, China or Russia. This study used an online questionnaire to identify and understand the main unmet
needs of individuals who had been recently diagnosed with T2D from these countries. Several potential
needs were identified, including the need for more information and support about food and diet, a new
noninvasive solution for blood glucose monitoring and increased awareness of T2D symptoms. Our study
also identified possible innovative solution to address these needs.
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Diabetes represents a significant global burden of disease, and Type 2 diabetes (T2D) accounts for approximately
90% of all diabetes cases worldwide [1]. Globally, an estimated 463 million people aged 20–79 years had diabetes
in 2019, and this number is projected to rise to 700 million by 2045. South America, Asia and Eastern Europe are
emerging as three major regions with an increasing prevalence of diabetes [1]. In Brazil, the burden attributable to
diabetes increased between 1990 and 2016 by 97.2% according to total years of life lost and by 117.9% according
to total years of life with disability [2]. The prevalence of diabetes in Brazil is estimated to be 11.9% when diagnosed
using a combination of fasting glucose levels, an oral glucose tolerance test and self-report [3]. In China, diabetes
was estimated to affect approximately 129.8 million adults (70.4 million men and 59.4 million women) in 2017 [4].
Based on a population-based study, the prevalence of diabetes in Russia is estimated to be 5.4% [5]. Brazil, China
and Russia are all upper middle income countries and form part of the Brazil, Russia, India, China and South
Africa (BRICS) group of countries, which represent approximately 40% of the global burden of disease [6]. In the
BRICS group, Brazil, China and Russia have shown better health system performance than other countries [7].
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In addition to being associated with substantial economic burden, particularly in low- and middle-income
countries [8], T2D has a negative impact on patient health-related quality of life (QoL) [9], with diabetic compli-
cations, hypertension and depression associated with reduced QoL [10]. T2D may also carry stigma, particularly
among individuals with a high body mass index, high glycated hemoglobin (HbA1c) levels or poor blood glucose
control [11].
An individual patient’s coping mechanisms for overall acceptance of T2D and its management may influence
their QoL; these mechanisms differ by sex and psychosocial factors [12]. At the time of T2D diagnosis, patients
often experience several emotional reactions that affect their ability to accept their diagnosis and adjust to self-
management, including denial, anger, guilt and depression [13]. It is therefore important for healthcare professionals
to provide appropriate psychosocial support to patients in order to improve their ability to accept responsibility for
self-management of their T2D, and to adopt specific strategies based on their patients’ emotions, with the aim of
improving their QoL [13].
Several studies have previously evaluated the unmet psychosocial needs of patients with diabetes, including
the Diabetes Attitudes, Wishes and Needs (DAWN) and DAWN2 studies in individuals with Type 1 diabetes
and T2D [14–18] and the DIABASIS study in individuals with T2D [19]. These studies highlighted the fact that
psychosocial problems are common among patients with diabetes, and that diabetes is associated with a significant
burden among patients, as well as their family members and healthcare professionals [14,16–19]. In particular, the
lack of adequate support from healthcare systems with regard to diabetes care and self-management appeared to
contribute to the development of psychosocial issues among patients with diabetes [14,16,17,19]. For example, in the
French DIABASIS study, many participants reported distress and a need for more information at the time of their
diagnosis, indicating a lack of proper diabetes education [19].
Several gaps exist in the literature regarding the unmet needs of patients with T2D. Of note, no recent studies
have evaluated the needs of patients with T2D in Brazil, China or Russia. There is also a need for information on
the sociomedical context of T2D diagnosis and patients’ needs prior to and immediately after diagnosis.
The objectives of the current study were to identify and understand the main unmet needs of individuals
with T2D from Brazil, China and Russia using a unique international web-based survey. This study was focused
on: understanding the burden of T2D and its impact from the patient perspective; identifying difficulties in the
patient’s journey from T2D diagnosis to management; and identifying potential solutions for use in everyday life,
and evaluating the patients’ perception and level of satisfaction with these solutions. The study was preceded by
qualitative research exercises used to build a deeper understanding of the patient experience and to select the most




This international study was performed by STETHOS International (Sèvres, France) and included individuals
with recently diagnosed T2D from Brazil, China and Russia.
The preliminary qualitative phase of the study involved two successive steps: in-depth, 60-min exploratory
interviews with 14 individuals from each country, conducted over the phone or face-to-face (depending on
patients’ preference) between April and May 2019, to obtain key insights regarding all aspects of the participants’
life that could be potentially impacted by T2D and its treatment; 2-h face-to-face focus groups conducted in July
2019 with 12 individuals from each country (two groups of six individuals each) to expand on the potential unmet
needs.
These qualitative research exercises were used to build a 50-question questionnaire (Supplementary Table 1),
with the main insights being used to test the relevance and wording of the included questions, and to ensure that the
appropriate list of items was used for the closed-ended questions. The goals of the 20-min web-based questionnaire,
which was used to survey 100 individuals from each country, were to: quantify the main unmet needs of individuals
with T2D; test and rank the final list of actionable solutions; and fine-tune specific solutions by testing different
alternatives.
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Study periods
The qualitative assessments (i.e., in-depth individual interviews and focus groups) were conducted between 25
April 2019 and 29 July 2019. The quantitative online questionnaires were conducted between 13 January and 11
February 2020.
Ethical considerations
Participants provided written informed consent prior to taking part in the qualitative interviews or focus groups or
in the quantitative questionnaire.
The study was conducted in accordance with the appropriate regional, national or local guidelines for non-
interventional studies, and used guidelines of the International Chamber of Commerce/European Society for
Opinion and Marketing Research [20], the European Pharmaceutical Market Research Association [21] and Good
Pharmacoepidemiology Practices [22] as a minimum standard.
Study participants
Individuals who had been recently diagnosed with T2D (between 2014 and 2019) and were currently receiving
any antidiabetic therapy were eligible to participate in the online questionnaire. Eligible participants were required
to have medical documentation of their T2D disease (e.g., a current prescription for an antidiabetic agent). No
additional inclusion or exclusion criteria were applied. The survey participant population was designed to have a
balanced mix of age groups and of males and females.
Participants were recruited through multiple channels, including healthcare professional referrals, existing panels,
medical centers, social media and word-of-mouth referral. Potential participants were administered screening
questions over the phone. Each participant received €10–15 for their participation in the survey.
Participant data were anonymized prior to this analysis, and the sponsor was blinded to the questionnaire
responses. The sponsor’s name was not disclosed to the participants in order to avoid research bias.
Outcomes
The following data were collected from completed online questionnaires: participant baseline characteristics;
details regarding the context of their T2D diagnosis, including the symptoms they experienced and the duration
of these symptoms prior to diagnosis, and diabetes knowledge prior to diagnosis; details regarding their first
T2D consultation, including the type of healthcare professional they saw, the duration of the visit, the diabetes
information they received and their levels of satisfaction with the information and support they were given; the
unmet needs of the participants based on their feelings and concerns, their ability to accept their diagnosis and
impact of their T2D diagnosis on QoL.
Participant diabetes knowledge prior to diagnosis was rated on a scale of 0–10, where 0 = ‘no knowledge’ and
10 = ‘extensive knowledge’.
Participant satisfaction regarding the amount of diabetes information they received from their healthcare profes-
sional was rated on a scale of 0–10, where 0 = ‘did not meet my expectations’ and 10 = ‘fully met my expectations’.
The impact on QoL at diagnosis, at 6 months after diagnosis and at the time of the survey was rated on a scale
of -5 to +5, where -5 = negative impact, 0 = no impact and +5 = positive impact.
Statistical analysis
The quantitative survey was designed to enroll 100 individuals with T2D from each of the three countries as a
sample of individuals with T2D treated with oral antidiabetic therapy.
The χ2 test for qualitative data and the Student t-test for quantitative data were used, with a significance




In total, 300 individuals with recently diagnosed T2D from Brazil, China and Russia (each n = 100) completed the
quantitative online questionnaire and were included in this analysis. The baseline characteristics of the participants
are summarized in Table 1. Overall, participants had a mean ± standard deviation age of 53 ± 10.8 years and
58% were female. There was a higher proportion of female than male participants in Brazil and Russia, while the
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Table 1. Participant baseline characteristics.
Characteristic, n (%) Total (N = 300) Brazil (N = 100)† China (N = 100)† Russia (N = 100)†
Age, years
– 40 41 (14) 21 12 8
– 40–49 69 (23) 26 25 18
– 50–60 102 (34) 28 34 40
– 61–70 88 (29) 25 29 34
Sex
– Male 125 (42) 35 51 39
– Female 175 (58) 65 49 61
Year of diagnosis
– 2014–2015 130 (43) 45 49 36
– 2016–2017 95 (32) 31 26 38
– 2018–2019 75 (25) 24 25 26
HbA1c at diagnosis
– 8% 91 (30) 24 30 37
– ≥8% 104 (35) 24 50 30
– Unknown 105 (35) 52 20 33
Antidiabetic therapy
– Oral 233 (78) 70 76 87
– Oral + injectable 67 (22) 30 24 13
CV comorbidities
– Hypertension 130 (43) 45 36 49
– Hypercholesterolemia 81 (27) 26 22 33
– Coronary artery disease 14 (5) 1 4 9
– Stable angina pectoris 9 (3) 2 2 5
Digital self-monitoring tools familiarity
– Very familiar 157 (52) 59 50 48
– Quite familiar 118 (39) 31 49 38
– Not familiar 25 (8) 10 1 14
†n and percentage values are the same as there are 100 participants from each country.
CV: Cardiovascular; HbA1c: Glycated hemoglobin.
proportions of male and female participants in China were similar. More participants in China had HbA1c levels
of >8 versus ≤8% at diagnosis, whereas similar proportions of Brazilian and Russian participants had HbA1c
levels >8 and ≤8%. Overall, the most common cardiovascular comorbidities reported by survey respondents




Almost all (94%) of the study participants experienced decompensated diabetes-related symptoms prior to their
diagnosis (93% in Brazil, 94% in China and 96% in Russia). The most common symptoms prior to diagnosis were
dry mouth (58%), excessive thirst (51%) and fatigue or drowsiness (48%; Table 2) but only 55% of all participants
(65% of participants in Brazil, 55% in China and 44% in Russia) sought medical attention for their symptoms
leading to diabetes diagnosis. The proportion of participants who were diagnosed after presenting with symptoms
was significantly higher in Brazil than in China and Russia combined (p = 0.011).
The T2D diagnosis was made by chance (i.e., either during a routine medical check-up or after self-glucometer
use) in 45% of all study participants, 35% of participants in Brazil, 45% in China and 56% in Russia. Of the
participants who were diagnosed by chance, a routine medical check-up led to the diagnosis in most cases (92% of
those diagnosed by chance in the overall study population, 94% in Brazil, 89% in China and 93% in Russia).
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Table 2. Most common symptoms experienced by participants before Type 2 diabetes diagnosis.
Symptom, n (%) Total (N = 300) Brazil (N = 100)† China (N = 100)† Russia (N = 100)†
Dry mouth 174 (58) 51 54 69‡
Excessive thirst 154 (51) 57 44 53
Fatigue/drowsiness 144 (48) 45 40§ 59‡
Frequent urination 132 (44) 64‡ 39 29§
Weakness/dizziness 104 (35) 42 15§ 47‡
Blurred vision 99 (33) 45‡ 23§ 31
Increased appetite 90 (30) 45‡ 22§ 23
Sudden weight loss 68 (23) 22 35‡ 11§
Trembling/sweating 67 (22) 24 13§ 30‡
Itchy skin 50 (17) 8§ 22 20
Healing issues 43 (14) 25‡ 4§ 14
†n and percentage values are the same as there are 100 participants from each country.
‡Significantly higher vs other countries combined.
§Significantly lower vs other countries combined.
Regardless of how T2D was diagnosed, only a third of participants with symptoms prior to diagnosis suspected
that they had T2D, mainly because of a family history of diabetes, with the highest percentage (44%) observed in
China (p = 0.007; compared with 28% in Brazil and 27% in Russia).
Participants reported an average diabetes knowledge score of 4.4 (on a scale from 0 to 10) before they were
diagnosed, with less than a quarter (23%) reporting a score ≥7.
After the onset of symptoms, participants sought medical attention regarding their T2D diagnosis after a
mean ± standard deviation of 11.5 ± 15.0 months (10.4 ± 13.4 months in Brazil, 11.7 ± 16.6 months in China
and 12.1 ± 14.7 months in Russia). The most common reasons for not seeking medical attention immediately
were that the symptoms were considered mild (43%) and a fear of diagnosis (36%).
First T2D consultation
Across all three countries, 198 (66%) participants had their first T2D consultation with a diabetes specialist
and 102 (34%) participants had their first visit with a general practitioner. A specialist initiated T2D treatment
in the majority of participants in China (89%) and Russia (75%); however, a significantly lower proportion of
participants had their first consultation with a diabetes specialist in Brazil (34%) than in China and Russia combined
(p < 0.001), reflecting country-specific diabetes care pathways.
Overall, the first T2D consultation had a mean duration of 26 min (26.3 min with specialists and 25.7 min with
general practitioners). The mean duration of the first visit was significantly longer among participants in Brazil
versus China and Russia (31 ± 17 vs 25 ± 17 and 22 ± 10 min, respectively; p < 0.001).
Participants reported that the quality and quantity of diabetes-related information they received at their first
T2D visit either ‘met their expectations’ or ‘fully met their expectations’ (corresponding to a rating of 9 or 10,
respectively) in 25% of cases for disease information, 33% for lifestyle information, 34% for treatment information
and 44% for blood glucose monitoring information. Using a 0–10 scale to rate their satisfaction, participants who
had their first consultation with a specialist had significantly higher mean satisfaction scores for lifestyle (7.3 vs
6.7, p = 0.047) and blood glucose monitoring (7.8 vs 6.9; p = 0.004) information versus those who saw a general
practitioner (Figure 1A); mean satisfaction scores for disease information (6.8 vs 6.2) and treatment information
(7.4 vs 6.8) were similar between healthcare professional types. By country, significantly lower mean satisfaction
scores were reported for disease information in Russia versus Brazil and China (6.1 vs 6.8 and 7.0, respectively;
p = 0.011); mean satisfaction scores were similar across countries for blood glucose information (7.1–7.7), lifestyle
information (6.8–7.3) and treatment information (6.9–7.3; Figure 1B).
Overall, 57% participants were either ‘satisfied’ or ‘very satisfied’ (corresponding to a rating of 9 or 10, respectively)
with the information and support they received at their first T2D consultation. Of those who saw a specialist
(n = 198), 54% were satisfied or very satisfied with their consultation. Of the 102 participants who saw a general
practitioner, 62% were either satisfied or very satisfied. In both situations, the proportion of patients who were
satisfied or very satisfied with their consultation was significantly higher in Brazil than in China and Russia
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Figure 1. Participant satisfaction. Level of satisfaction of participants regarding the information received at the time
of Type 2 diabetes diagnosis (A) by whether the first visit was conducted by a general practitioner or a specialist and
(B) by country.
*Value is significantly lower versus specialists.
†Percentage is significantly lower versus other countries combined.
combined (for specialists: 94 vs 52 and 40%, respectively; p < 0.001; for general practitioners: 75 vs 36 and 40%,
respectively; p < 0.001). On average, satisfied or very satisfied patients had longer first visits (30 min) compared
with dissatisfied patients (17 min).
Participants’ feelings
At the time of their T2D diagnosis, the majority of all participants reported having felt apprehension or fear (51%)
and denial or difficulty with acceptance of their diagnosis (32%; Figure 2). The most common fears and concerns
at diagnosis were the risk of severe complications (63%) and multiple food restrictions (47%; Figure 3). The main
diabetic complications of concern were vision impairment (67%), diabetic foot (60%) and heart disease (40%).
Approximately two-thirds of all participants said they had accepted their T2D diagnosis either immediately
(27%) or within a few days (20%) or weeks (19%). The remaining participants accepted their diagnosis after a few
months (25%) or years (4%), or had still not accepted their diagnosis (5%). Of note, participants with a shorter
time to acceptance of T2D diagnosis (within a few weeks) had a significantly greater diabetes-related knowledge
prior to diagnosis (4.7/10 on average) than those who accepted the disease within a few months or years (3.9/10;
p = 0.0137).
Impact on QoL
On a scale of -5 to +5, T2D diagnosis had a negative impact on QoL (score of -5/-4 or -3/-2) in 44% of all
participants immediately after their diagnosis, 29% at 6 months after diagnosis and 19% at the time of the survey.
The proportion of participants who reported QoL recovery or improvement (score of -1/+1, +2/+3 or +4/+5)
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Figure 2. Most common emotions of participants at Type 2 diabetes diagnosis in the overall study population (bar
graph) and in each country (table).
*Percentage is significantly higher versus other countries combined.
†Percentage is significantly lower versus other countries combined.
increased from 56% immediately after diagnosis to 71% at 6 months and 81% at the time of the survey. Mean
QoL scores were significantly lower in Russia than Brazil or China immediately after diagnosis (-1.6 vs -0.1 and
-1.0; p = 0.001), at 6 months (-0.7 vs +0.9 and 0; p < 0.001), and at the time of the survey (-0.3 vs +1.8 and
+0.3; p < 0.001).
Unmet needs in T2D
The main unmet needs identified by all participants were more information and support regarding food and diet
(36%), a new solution to monitor blood glucose levels (36%) and increased awareness of T2D to facilitate earlier
diagnosis (26%; Figure 4). Among those who identified a need for a new solution to monitor blood glucose levels,
many participants expressed a need for a noninvasive, painless device (43%) and real-time tracking of blood glucose
levels (36%).
In the first few months after their T2D diagnosis, the majority of all participants (84%) felt supported by their
family and friends and 55% felt supported by their healthcare professional. Besides healthcare professionals, the
main source of diabetes-related information for all participants was their family and friends (59%), followed by the
internet (48%), medical television programs (25%), medical literature and press (15%) and social networks (11%).
Participants used these sources mostly to look for information about food and diet (71%) and long-term disease
complications (49%).
According to all participants, the most appropriate format for providing diabetes-related information and support
was a smartphone application (52%), followed by patient training events (18%), a web site (17%) and printed
material (13%). Similarly, most participants in Brazil and China stated that a smartphone application was the best
format (59 and 65%, respectively), while opinion was more divided in Russia (29% for smartphone application,
28% for printed material, 25% for website and 18% for patient training).
More than half of all participants (58%) stated that the most appropriate channel for providing information
about a new solution for individuals living with diabetes was through their healthcare professional. The majority
of participants in China (57%) and Russia (67%) also stated that this information should be provided by their
future science group 10.2217/cer-2020-0271
Research Article Raposo, Shestakova, Lu, Court & Mayorov
No fear or concern
Negative impact on social life
Negative impact on career
Negative impact on family
Cost of anti-diabetic drug
Risk of severe complication
Multiple food restrictions
Side effect of anti-diabetic drugs
Risk of high blood glucose fluctuation
Need for regular blood glucose testing
Insulin injection

















































Overall (n = 300)
Brazil (n = 100)
China (n = 100)
Russia (n = 100)
Figure 3. Most common fears and concerns of participants at Type 2 diabetes diagnosis.
*Percentage is significantly higher versus other countries combined.
†Percentage is significantly lower versus other countries combined.
healthcare professional, and participants in Brazil stated that new information should be disseminated by their
healthcare professional (49%) or through social networks (46%).
If a new digital solution providing diabetes information and support were to become available, most participants
favored an “all-in-one” comprehensive approach with information about diabetes and other conditions associated
with cardiovascular risk (85% of all participants, 89% in Brazil, 86% in China and 80% in Russia).
Discussion
This international web-based survey identified several potential patient-related concerns and unmet needs among
individuals with T2D in Brazil, China and Russia.
With regard to the T2D diagnosis context, almost half of the participants (45%) were diagnosed by chance
during a routine check-up, while 55% of participants sought medical attention because of diabetes-related symptoms
(mainly dry mouth, excessive thirst and fatigue). Despite 94% of participants having symptoms prior to diagnosis,
only a third of these participants suspected diabetes, primarily because of a family history of the disease. On average,
participants waited almost 1 year after developing symptoms before seeking medical attention, mainly because they
felt their symptoms were not severe enough or they were afraid of the diagnosis. These findings indicate that there
is a need to disseminate general diabetes information to increase overall awareness of symptoms and the importance
of visiting a healthcare professional as soon as they develop, and to address the fear induced by a diabetes diagnosis
in some people.
At the time of their T2D diagnosis, most participants felt fear and apprehension, and had difficulty accepting
their disease. The participants’ main concerns were the development of severe complications, including vision
impairment, diabetic foot and heart disease, and multiple food restrictions, while chronic kidney disease was
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Figure 4. Main unmet needs of participants with Type 2 diabetes in the overall study population (bar graph) and in
each country (table).
*Percentage is significantly higher versus other countries combined.
†Percentage is significantly lower versus other countries combined.
T2D: Type 2 diabetes.
mentioned as a concern by a minority of patients. After diagnosis, participants reported using the internet to seek
further diabetes-related information, mainly about food and diet advice and long-term disease complications.
When comparing participants’ responses between countries, more participants in Brazil than in China and
Russia sought medical attention for diabetes-related symptoms, while more participants in Russia than in Brazil
and China were diagnosed with T2D by chance. The proportion of participants who had their first consultation
with a diabetes specialist was lower in Brazil than in other countries; however, the mean duration of the first visit was
longer in Brazil than in other countries. More participants in Brazil versus other countries combined were satisfied
overall with their first T2D consultation. Participants reported lower mean satisfaction scores for the amount of
disease information in Russia than in other countries. Mean QoL scores were lower in Russia versus other countries
immediately after diagnosis, at 6 months after diagnosis and at the time of the survey.
The participants’ perspectives in our study are consistent with and add to those of previous studies that examined
the unmet needs of patients with diabetes. In the cross-national DAWN study (which included patients from 13
countries including Australia, India, Japan, the USA and a number in Europe), the majority of participants reported
diabetes-related psychological problems, including anxiety, depression and stress, as well as poor psychological well-
being [17]. Many healthcare professionals could not identify these psychological problems or provide the support to
their patients [17]. Similarly, in the DAWN2 study (of patients in 18 countries), healthcare professionals reported that
access to quality care was poor and more diabetes-related training is needed [14]. Diabetes was associated with physical,
emotional, social and financial impact on the participants’ lives and presented many psychosocial challenges. The
majority of participants did not feel that they received sufficient support from a healthcare professional, despite this
being a high priority for most. The DAWN2 study identified unmet needs in the availability of psychosocial support,
self-management education and person-centered diabetes care [14,16]. Participants also reported several challenges
with regard to the impact of diabetes on work (and vice versa) [18]. In the DIABASIS study, the shortcomings
of the diabetes healthcare system in France were highlighted by most participants, who reported high levels of
distress at the time of their diagnosis, as well as the need for more information to help cope with this distress [19].
The importance of educational activities and the need for information at disease onset were under-recognized and
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routine healthcare professional visits were too short for in-depth counseling. Similar to the DAWN studies, many
participants reported feelings of anxiety, depression and helplessness, fear, dismay or anger [19].
In our study, the main potential unmet needs were more information and support about food and diet, a new
solution for noninvasive monitoring blood glucose levels and increased awareness of T2D symptoms to possibly
allow for earlier diagnosis. Although the benefits of self-monitoring of blood glucose in patients with T2D who are
not receiving insulin are questionable [23,24], noninvasive monitoring devices may address a lack of adherence due to
the pain of invasive monitoring techniques [25]. In our study, most participants (78%) were not receiving injectable
therapy at the time of the survey; however, our results indicate that the participants recognized the potential benefits
of a noninvasive, painless device for blood glucose monitoring, particularly once insulin therapy was ultimately
needed. The participants also expressed a need for consistent and detailed guidelines and support regarding their
food and diet.
Our study also identified possible opportunities for innovative solutions to address these unmet needs. A
smartphone application was considered the most appropriate format for providing a new solution for individuals
living with T2D and other conditions associated with increased cardiovascular risk, and if available, should be
recommended by healthcare professionals. The participants favored an ‘all-in-one’ approach that covers multiple
topics related to disease management, including disease information, food and diet, blood glucose control, lifestyle,
treatment and potential complications, rather than a diabetes-only option.
The main strengths of our study were its large study population of individuals with confirmed T2D diagnosis
from three countries and its robust three-phase methodology. Using a sequential approach, our study developed a
quantitative questionnaire that was built entirely from participant feedback, allowing us to form reliable conclusions
from our findings. In addition, the multi-channel method of recruitment allowed us to have a varied sample of
the T2D population. Participants responding to an online questionnaire are probably more willing to share
their experiences as they feel free to express themselves anonymously without their doctor’s involvement. As
this was a self-reported questionnaire, the main study limitations were the possibility of bias in the participant
responses (i.e., sampling bias, nonresponse bias and recall bias), which is common in web-based surveys and the
exclusion of individuals diagnosed with T2D before 2014. There was also the possibility of selection bias, as
participants responding to an online questionnaire may be more likely to use a smart phone application for disease
information and management than the general population. Another limitation is that the diagnosis and clinical
data collected were not provided by healthcare professionals but rather by participants themselves (i.e., current
medical prescription, diagnosis evidence), except for the individuals with T2D recruited via their practicing doctor
(e.g., about 40% in Brazil), which may lead to recall bias. Further, the samples from each country were not fully
representative of the general population of patients with diabetes in each country, in particular regarding the
male/female ratio in the samples from China and Russia [4,5] and the age groups of the sample from Brazil [3].
However, the participant baseline characteristics were generally well balanced between countries, thus reducing the
risk of major bias when comparing countries. Finally, individuals who do not have computer or internet access were
excluded, which may lead to a potential recruitment bias.
Conclusion
This international web-based survey identified several potential unmet needs among individuals with T2D in
Brazil, China and Russia, including the need for more information and support regarding food and diet, the need
for a new solution for noninvasive monitoring blood glucose levels, and the need for increased awareness of T2D
symptoms, which may facilitate earlier diagnosis. Several possible innovative solutions were identified, although
further research is needed to confirm whether these solutions can help to address these needs.
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Summary points
• Several gaps exist in the literature regarding the unmet needs of patients with Type 2 diabetes (T2D), particularly
prior to and immediately after their diagnosis.
• We report the results of the final phase of an online quantitative questionnaire conducted with 300 individuals
with newly diagnosed T2D in Brazil, China and Russia.
• Most participants (94%) experienced diabetes-related symptoms prior to diagnosis, but a T2D diagnosis was
suspected in only a third of these participants.
• Mean satisfaction scores were lower for disease information received at the time of T2D diagnosis by healthcare
professional in Russia than in other countries.
• Mean quality of life scores were lower in Russia than in other countries immediately after and at 6 months after
diagnosis and at the time of the survey.
• Several unmet needs were identified, including the need for more information and support about food and diet,
a new solution for monitoring blood glucose levels and an increased awareness of T2D to allow for earlier
diagnosis.
• Opportunities for innovative therapeutic solutions to address the unmet needs in individuals with T2D were
identified.
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